Hematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer.

[1]  R. Sandler,et al.  Dietary Patterns, Food Groups, and Rectal Cancer Risk in Whites and African-Americans , 2009, Cancer Epidemiology Biomarkers & Prevention.

[2]  B. Molnár,et al.  Potential Biomarkers of Colorectal Adenoma–Dysplasia–Carcinoma Progression: mRNA Expression Profiling and In Situ Protein Detection on TMAs Reveal 15 Sequentially Upregulated and 2 Downregulated Genes , 2008, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[3]  S. Narumiya,et al.  Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo , 2008, Proceedings of the National Academy of Sciences.

[4]  M. Reilly,et al.  Tetranor PGDM, an Abundant Urinary Metabolite Reflects Biosynthesis of Prostaglandin D2 in Mice and Humans* , 2008, Journal of Biological Chemistry.

[5]  Henry J. Lin,et al.  Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice. , 2007, Cancer research.

[6]  K. Lundholm,et al.  Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression , 2007, Acta oncologica.

[7]  William L. Smith,et al.  The 19-amino Acid Cassette of Cyclooxygenase-2 Mediates Entry of the Protein into the Endoplasmic Reticulum-associated Degradation System* , 2006, Journal of Biological Chemistry.

[8]  R. Millikan,et al.  COX-2 Polymorphism, Use of Nonsteroidal Anti-Inflammatory Drugs, and Risk of Colon Cancer in African Americans (United States) , 2006, Cancer Causes & Control.

[9]  A. Ciechanover.  Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin–proteasome system and onto human diseases and drug targeting* , 2005, Cell Death and Differentiation.

[10]  J. Morrow,et al.  Contribution of Cyclooxygenase-2 to Elevated Biosynthesis of Thromboxane A2 and Prostacyclin in Cigarette Smokers , 2005, Circulation.

[11]  S. Chanock,et al.  Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. , 2004, Carcinogenesis.

[12]  R. Langer,et al.  The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. , 2003, Annals of epidemiology.

[13]  Y. Urade,et al.  Hematopoietic prostaglandin D synthase. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[14]  Y. Kai,et al.  Mechanism of metal activation of human hematopoietic prostaglandin D synthase , 2003, Nature Structural Biology.

[15]  S. Reddy,et al.  Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Christopher F. Martin,et al.  5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  Christopher F. Martin,et al.  Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas. , 2002, Gastroenterology.

[18]  Henry J. Lin,et al.  Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  Y. Urade,et al.  Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. , 2002, Prostaglandins & other lipid mediators.

[20]  H. Tai,et al.  Prostaglandin catabolizing enzymes. , 2002, Prostaglandins & other lipid mediators.

[21]  T. Arinami,et al.  New polymorphisms of haematopoietic prostaglandin D synthase and human prostanoid DP receptor genes , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  D. Bell,et al.  Functional characterization of cyclooxygenase-2 polymorphisms. , 2001, The Journal of pharmacology and experimental therapeutics.

[23]  P. Murdock,et al.  Mammalian class Sigma glutathione S-transferases: catalytic properties and tissue-specific expression of human and rat GSH-dependent prostaglandin D2 synthases. , 2001, The Biochemical journal.

[24]  William L. Smith,et al.  Prostaglandin Endoperoxide H Synthase-1 , 2001, The Journal of Biological Chemistry.

[25]  J. Morrow,et al.  Regulation of Constitutive Cyclooxygenase-2 Expression in Colon Carcinoma Cells* , 2000, The Journal of Biological Chemistry.

[26]  C. Clish,et al.  Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing , 2000, The Journal of experimental medicine.

[27]  D. Lieberman,et al.  Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. , 2000, The New England journal of medicine.

[28]  Y. Urade,et al.  Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Narumiya,et al.  Prostaglandin D2 as a mediator of allergic asthma. , 2000, Science.

[30]  D O Stram,et al.  A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. , 2000, American journal of epidemiology.

[31]  W. Cho,et al.  A Structure-Function Study of the C2 Domain of Cytosolic Phospholipase A2 , 1999, The Journal of Biological Chemistry.

[32]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[33]  B. Mannervik,et al.  Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. , 1998, Journal of molecular biology.

[34]  J. Witte,et al.  A sigmoidoscopy‐based case–control study of polyps: macronutrients, fiber and meat consumption , 1997, International journal of cancer.

[35]  Y. Urade,et al.  Prostaglandin D Synthase in Human Megakaryoblastic Cells* , 1997, The Journal of Biological Chemistry.

[36]  R. Kikuno,et al.  Cloning and Crystal Structure of Hematopoietic Prostaglandin D Synthase , 1997, Cell.

[37]  S. Iacobelli,et al.  Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. , 1994, The Journal of pharmacology and experimental therapeutics.

[38]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[39]  Y. Urade,et al.  The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. , 1989, Journal of immunology.

[40]  Y. Urade,et al.  Characterization and distribution of prostaglandin D synthetase in rat skin. , 1988, The Journal of investigative dermatology.

[41]  Y. Urade,et al.  Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. , 1988, Archives of biochemistry and biophysics.

[42]  Y. Urade,et al.  Biochemical and immunological characterization of rat spleen prostaglandin D synthetase. , 1987, The Journal of biological chemistry.

[43]  O. Hayaishi,et al.  Prostaglandin D2 induces sleep when microinjected into the preoptic area of conscious rats. , 1982, Biochemical and biophysical research communications.

[44]  E. Christ-Hazelhof,et al.  Purification and characterisation of prostaglandin endoperoxide D-isomerase, a cytoplasmic, glutathione-requiring enzyme. , 1979, Biochimica et biophysica acta.

[45]  D. Nugteren,et al.  Isolation and properties of intermediates in prostaglandin biosynthesis. , 1973, Biochimica et biophysica acta.

[46]  B. Samuelsson,et al.  Biosynthesis of 9α,15-Dihydroxy-11-ketoprost-13-enoic Acid , 1968 .

[47]  Andreas Matouschek,et al.  Targeting proteins for degradation. , 2009, Nature chemical biology.

[48]  Y. Kanaoka.  Hematopoietic prostaglandin D synthase. Prostaglandins Leukot , 2003 .

[49]  A. Goldberg,et al.  Intracellular protein degradation in mammalian and bacterial cells: Part 2. , 1976, Annual review of biochemistry.

[50]  A. Goldberg,et al.  Intracellular protein degradation in mammalian and bacterial cells. , 1974, Annual review of biochemistry.